Separating the samples by TNBC status decreases this p value by 10-fold, and adding AR-negative samples to the TNBC cohort, referred to as quadruple negative breast cancer (QNBC), further increases the significance of the difference. The gene discussed is AR; the disease is breast carcinoma.